HL Deb 12 March 2001 vol 623 cc62-3WA
Lord Roberts of Conwy

asked Her Majesty's Government:

Whether anti-TNF therapy for rheumatoid arthritis is available in rheumatology departments at teaching hospitals in England. [HL1114]

Lord Hunt of Kings Heath

Infliximab (Remicade) and entanercept (Enbrel) are currently being appraised by the National Institute for Clinical Excellence (NICE). Until NICE has completed its appraisal, National Health Service bodies have been advised to use their existing arrangements to determine local policies on the publicly available evidence.

Back to